A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab

A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal medicine journal 2021-04, Vol.51 (4), p.616-617
Hauptverfasser: Cashman, Helen, Roberts, Darren M., Welch, Susan, Joseph, Joanne
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 617
container_issue 4
container_start_page 616
container_title Internal medicine journal
container_volume 51
creator Cashman, Helen
Roberts, Darren M.
Welch, Susan
Joseph, Joanne
description
doi_str_mv 10.1111/imj.15278
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2516481556</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2516481556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2808-233dad78795e7b374430b8592e82bf13e5cba8cdd1a7348ed0244349cbf068333</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqUw8AeQJSaGtHZsJ85YVXwUFbHAHDn2BVLSuNhJUfn1uE1hw8udrMfP-V6ELikZ03Am1Wo5piJO5REaUs5FJLKMH-97HpGMsAE6835JCE1Zxk_RgDEZbhM2RDDFWnnAtsQKr5T7AFNvMdSwUS0YbFRRvanWqQZr22hoQttWtsEOfOVb1bS4tbh9B6zWa2c3uye211VGuU5X391KFefopFS1h4tDHaHXu9uX2UO0eL6fz6aLSMeSyChmzCiTyjQTkBYs5ZyRQoosBhkXJWUgdKGkNoaqlHEJhsQB4ZkuSpJIxtgIXffe8JfPDnybL23nmjAyjwVNuKRCJIG66SntrPcOynztqrD7Nqck3wWah0DzfaCBvToYu2IF5o_8TTAAkx74qmrY_m_K50-PvfIHmBF_kA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2516481556</pqid></control><display><type>article</type><title>A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cashman, Helen ; Roberts, Darren M. ; Welch, Susan ; Joseph, Joanne</creator><creatorcontrib>Cashman, Helen ; Roberts, Darren M. ; Welch, Susan ; Joseph, Joanne</creatorcontrib><identifier>ISSN: 1444-0903</identifier><identifier>EISSN: 1445-5994</identifier><identifier>DOI: 10.1111/imj.15278</identifier><identifier>PMID: 33890363</identifier><language>eng</language><publisher>Melbourne: John Wiley &amp; Sons Australia, Ltd</publisher><ispartof>Internal medicine journal, 2021-04, Vol.51 (4), p.616-617</ispartof><rights>2021 Royal Australasian College of Physicians</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2808-233dad78795e7b374430b8592e82bf13e5cba8cdd1a7348ed0244349cbf068333</cites><orcidid>0000-0002-3595-4256</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fimj.15278$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fimj.15278$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33890363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cashman, Helen</creatorcontrib><creatorcontrib>Roberts, Darren M.</creatorcontrib><creatorcontrib>Welch, Susan</creatorcontrib><creatorcontrib>Joseph, Joanne</creatorcontrib><title>A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab</title><title>Internal medicine journal</title><addtitle>Intern Med J</addtitle><issn>1444-0903</issn><issn>1445-5994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kD1PwzAQhi0EoqUw8AeQJSaGtHZsJ85YVXwUFbHAHDn2BVLSuNhJUfn1uE1hw8udrMfP-V6ELikZ03Am1Wo5piJO5REaUs5FJLKMH-97HpGMsAE6835JCE1Zxk_RgDEZbhM2RDDFWnnAtsQKr5T7AFNvMdSwUS0YbFRRvanWqQZr22hoQttWtsEOfOVb1bS4tbh9B6zWa2c3uye211VGuU5X391KFefopFS1h4tDHaHXu9uX2UO0eL6fz6aLSMeSyChmzCiTyjQTkBYs5ZyRQoosBhkXJWUgdKGkNoaqlHEJhsQB4ZkuSpJIxtgIXffe8JfPDnybL23nmjAyjwVNuKRCJIG66SntrPcOynztqrD7Nqck3wWah0DzfaCBvToYu2IF5o_8TTAAkx74qmrY_m_K50-PvfIHmBF_kA</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Cashman, Helen</creator><creator>Roberts, Darren M.</creator><creator>Welch, Susan</creator><creator>Joseph, Joanne</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-3595-4256</orcidid></search><sort><creationdate>202104</creationdate><title>A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab</title><author>Cashman, Helen ; Roberts, Darren M. ; Welch, Susan ; Joseph, Joanne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2808-233dad78795e7b374430b8592e82bf13e5cba8cdd1a7348ed0244349cbf068333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cashman, Helen</creatorcontrib><creatorcontrib>Roberts, Darren M.</creatorcontrib><creatorcontrib>Welch, Susan</creatorcontrib><creatorcontrib>Joseph, Joanne</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal medicine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cashman, Helen</au><au>Roberts, Darren M.</au><au>Welch, Susan</au><au>Joseph, Joanne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab</atitle><jtitle>Internal medicine journal</jtitle><addtitle>Intern Med J</addtitle><date>2021-04</date><risdate>2021</risdate><volume>51</volume><issue>4</issue><spage>616</spage><epage>617</epage><pages>616-617</pages><issn>1444-0903</issn><eissn>1445-5994</eissn><cop>Melbourne</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>33890363</pmid><doi>10.1111/imj.15278</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-3595-4256</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1444-0903
ispartof Internal medicine journal, 2021-04, Vol.51 (4), p.616-617
issn 1444-0903
1445-5994
language eng
recordid cdi_proquest_journals_2516481556
source Wiley Online Library Journals Frontfile Complete
title A case of a markedly elevated dabigatran concentration resistant to the approved dose of idarucizumab
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T01%3A33%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20a%20markedly%20elevated%20dabigatran%20concentration%20resistant%20to%20the%20approved%20dose%20of%20idarucizumab&rft.jtitle=Internal%20medicine%20journal&rft.au=Cashman,%20Helen&rft.date=2021-04&rft.volume=51&rft.issue=4&rft.spage=616&rft.epage=617&rft.pages=616-617&rft.issn=1444-0903&rft.eissn=1445-5994&rft_id=info:doi/10.1111/imj.15278&rft_dat=%3Cproquest_cross%3E2516481556%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2516481556&rft_id=info:pmid/33890363&rfr_iscdi=true